If you are having trouble viewing this email, please use the address below:
 By Neil B. Gailmard, OD, MBA, FAAO, Editor April 26, 2006 - Tip #223 
 Contact Dr. Gailmard | Subscribe | Archives | Print this issue Visit: optometricmanagement.com 
More Thoughts on Pupil Dilation

  Sponsor: VISTAKON®
Wet Lens, Patient Satisfaction
Among those ages 35-49, 65% of patients who consider dropping out of contact lens wear cite dryness sensation as a key reason. ACUVUE® OASYS™ Brand Contact Lenses with HYDRACLEAR™ Plus are made from senofilcon A, a next generation silicone hydrogel. The proprietary formulation includes a remarkable moisture-rich wetting agent and no surface coating. The senofilcon A material balances properties to meet the demands of contact lens wearers in environments that can make eyes feel tired and dry. This breakthrough material creates a lens so moist and smooth that an eyelid glides effortlessly over it. ACUVUE® OASYS™ Brand Contact Lenses can help keep your patients in contact lenses by increasing their comfort and also giving them crisp vision and healthy lens wear.
Additional Information

Last week I covered an idea to make pupil dilation more efficient in the office, and this week I'll offer some more tips and ideas on that topic.

Delegate refraction

I recently acquired two computerized refraction systems in my practice, which allows technicians to assist with subjective refraction testing. While most doctors utilize these instruments to save time spent on gathering refractive data, there is an additional benefit with pupil dilation. Once the subjective refraction is done, the technician can check anterior chamber angles with a slit lamp and fully dilate the patient with tropicamide. When the doctor sees the patient, he is already dilated, saving the need to instill drops and see the patient back a second time. The distance subjective refraction can even be fine tuned or confirmed by the doctor in the dilated state.

Pre-dilate older patients

Some doctors have their technicians pre-dilate their patients that are 55 years of age or older, using a drug with tropicamide. The doctor does the refraction with the eye dilated and somewhat cyclopleged, but the reasoning is that patients in this age group have little accommodation and the refractive result will be the same.

Instill drops upon entering

This technique works well in conjunction with last week's tip when the eyes are pre-dilated with phenylephrine 2.5%. With the phenylephrine already working, the doctor may add 1 drop of tropicamide to each eye immediately after greeting the patient during the doctor part of the visit. Then the doctor does his or her usual tests: reviews case history, refraction, slit lamp, discusses some of the findings and recommendations, and finally does the fundus exam. At this point, the phenylephrine has had about 40 minutes to work and the tropicamide might have had close to 15 minutes. This technique can provide a fully dilated pupil in many patients and allow a peripheral retinal exam with a BIO.

Choice of drugs

We have a need for several different mydriatic drops for various applications and types of patients. Some patients, such as those with dark pigmentation and diabetics, are harder to dilate and may require a stronger drug concentration. In some cases we want a stronger cycloplegic affect for checking true refractive status or for pain relief. In some cases we want a fast acting drug that has a short acting cycloplegic effect, so our patients can return to work with little inconvenience. Generally, we use phenylephrine (Neosynephrine) 2.5%, tropicamide (Mydriacyl) .5% and 1%, and cyclopentolate (Cyclogyl) .5% and homatropine 5%.

For routine fundus evaluations Paremyd is an excellent choice because it has only .25% tropicamide - less than any other formulation. This low dose is sufficient for good pupil dilation, but it has reduced cycloplegic action and quicker recovery time. Paremyd is a combination drug: tropicamide along with hydroxyamphetamine (which used to be sold under the brand name Paredrine), so there is a cross action mydriasis. Hydroxyamphatmine does not cycloplege and is similar to phenylephrine. Paremyd was off the market for awhile - but is now available again from Akorn.

Best wishes for continued success,

Read Past Tips Neil B. Gailmard, OD, MBA, FAAO
Editor, Optometric Management Tip of the Week

A Proud Supporter of

Send questions and comments to neil@gailmard.com.

Dr. Gailmard offers consulting services to eye care professionals through Prima Eye Group; information is available at www.primaeyegroup.com.

Please Note: The views expressed in Management Tip of the Week do not necessarily reflect those of the sponsor.

Click to open a printer-friendly version of this tip.
Published by PentaVision LLC Copyright © 2002 - 2016 PentaVision LLC. All Rights Reserved.

If you prefer not to receive e-mail, please use the following link to remove your e-mail address from this list: Unsubscribe
This message was transmitted by PentaVision LLC, 321 Norristown Road, Suite 150, Ambler, PA 19002 | 215-628-6550
View the PentaVision LLC Privacy Policy | Contact Us
Please make sure our e-mail messages don't get marked as spam by adding visioncareprofessionalemail.com to your "approved senders" list. Please do not reply to this e-mail message.